According to the SEC Form 4 filings, Amado Rafael, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $674,994 | 5 | 100 |
| 2026-04-06 | Sale | Zai Lab Limited ZLAB | See Remarks | 2,739 0.0025% | $20.45 | $56,007 | +5.56% | |
| 2026-04-02 | Sale | Zai Lab Limited ZLAB | See Remarks | 9,910 0.009% | $20.39 | $202,065 | +5.78% | |
| 2026-03-13 | Sale | Zai Lab Limited ZLAB | See Remarks | 2,957 0.0027% | $18.63 | $55,083 | +13.94% | |
| 2026-03-03 | Sale | Zai Lab Limited ZLAB | See Remarks | 10,000 0.0085% | $17.38 | $173,800 | +16.87% | |
| 2025-12-31 | Sale | Zai Lab Limited ZLAB | See Remarks | 10,787 0.0096% | $17.43 | $188,039 | +11.96% | |
| 2025-08-08 | Sale | Zai Lab Limited ZLAB | See Remarks | 3,000 0.0027% | $35.00 | $105,000 | -43.51% | |
| 2025-04-04 | Sale | Zai Lab Limited ZLAB | See Remarks | 3,029 0.0292% | $33.11 | $100,284 | -8.91% | |
| 2025-04-02 | Sale | Zai Lab Limited ZLAB | See Remarks | 7,541 0.0686% | $35.89 | $270,677 | -20.15% | |
| 2025-03-17 | Sale | Zai Lab Limited ZLAB | See Remarks | 3,000 0.0278% | $38.41 | $115,230 | -21.15% | |
| 2024-12-31 | Sale | Zai Lab Limited ZLAB | See Remarks | 7,583 0.007% | $26.28 | $199,289 | +20.54% | |
| 2024-08-12 | Sale | Zai Lab Limited ZLAB | See Remarks | 3,115 0.0031% | $16.20 | $50,463 | +80.15% | |
| 2024-04-04 | Sale | Zai Lab Limited ZLAB | See Remarks | 1,952 0.002% | $15.67 | $30,594 | +59.22% | |
| 2024-03-15 | Sale | Zai Lab Limited ZLAB | See Remarks | 2,544 0.0026% | $18.86 | $47,980 | +12.89% | |
| 2024-01-02 | Sale | Zai Lab Limited ZLAB | See Remarks | 19,363 0.0199% | $26.30 | $509,169 | -23.33% | |
| 2022-08-02 | Sale | Allogene Therapeutics, Inc. ALLO | EVP of R&D and CMO | 2,000 0.0013% | $11.97 | $23,940 | -48.04% | |
| 2022-07-05 | Sale | Allogene Therapeutics, Inc. ALLO | EVP of R&D and CMO | 2,000 0.0014% | $11.44 | $22,880 | -38.52% | |
| 2022-06-21 | Sale | Allogene Therapeutics, Inc. ALLO | EVP of R&D and CMO | 2,000 0.0014% | $11.18 | $22,360 | -30.17% | |
| 2022-05-19 | Sale | Allogene Therapeutics, Inc. ALLO | EVP of R&D and CMO | 11,500 0.0079% | $7.40 | $85,092 | +18.54% | |
| 2022-03-15 | Sale | Allogene Therapeutics, Inc. ALLO | EVP of R&D and CMO | 5,169 0.0036% | $7.71 | $39,848 | +21.54% | |
| 2021-10-01 | Sale | Allogene Therapeutics, Inc. ALLO | EVP of R&D and CMO | 11,507 0.0084% | $24.35 | $280,185 | -51.55% |